Key result
Microalbuminuria strongly predicts cardiovascular morbidity and mortality, clinical nephropathy, and progression of renal disease in high-risk populations.
Why the study?
Is microalbuminuria a valid predictor of cardiovascular risk in high-risk populations?
Population
High-risk populations including patients with type 2 diabetes, older patients with type 1 diabetes, and…
Design
Review
Authors
Loading...
Supports microalbuminuria as CV/renal risk marker in high-risk groups; leaves open whether screening improves outcomes in trials.
Is microalbuminuria a valid predictor of cardiovascular risk in high-risk populations?
Microalbuminuria is a strong predictor of cardiovascular and renal outcomes, warranting routine screening in high-risk diabetic and hypertensive patients.
Tagle et al. (2003) studied this question. Microalbuminuria strongly predicts cardiovascular morbidity and mortality, clinical nephropathy, and progression of renal disease in high-risk populations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: